Metabolomic Profile Predicts Development of Microalbuminuria in Individuals with Type 1 Diabetes

[1]  A. Krolewski,et al.  Response to Comment on Niewczas et al. Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease. Diabetes Care 2017;40:383–390 , 2017, Diabetes Care.

[2]  P. Cassano,et al.  Erythritol is a pentose-phosphate pathway metabolite and associated with adiposity gain in young adults , 2017, Proceedings of the National Academy of Sciences.

[3]  J. Bonventre,et al.  Circulating Modified Metabolites and a Risk of ESRD in Patients With Type 1 Diabetes and Chronic Kidney Disease , 2017, Diabetes Care.

[4]  C. Gieger,et al.  Metformin Effect on Nontargeted Metabolite Profiles in Patients With Type 2 Diabetes and in Multiple Murine Tissues , 2016, Diabetes.

[5]  C. Gieger,et al.  Metabolites of milk intake: a metabolomic approach in UK twins with findings replicated in two European cohorts , 2016, European Journal of Nutrition.

[6]  T. Spector,et al.  Characterizing Blood Metabolomics Profiles Associated with Self-Reported Food Intakes in Female Twins , 2016, PloS one.

[7]  U. Andersson,et al.  Metabolomic screening of pre-diagnostic serum samples identifies association between α- and γ-tocopherols and glioblastoma risk , 2016, Oncotarget.

[8]  E. Ferrannini,et al.  Prediction of Declining Renal Function and Albuminuria in Patients With Type 2 Diabetes by Metabolomics. , 2016, The Journal of clinical endocrinology and metabolism.

[9]  Hyungwon Choi,et al.  Plasma Metabonomic Profiling of Diabetic Retinopathy , 2016, Diabetes.

[10]  Jean-Michel Poggi,et al.  VSURF: An R Package for Variable Selection Using Random Forests , 2015, R J..

[11]  D. Zeeuw,et al.  Urine and plasma metabolites predict the development of diabetic nephropathy in individuals with Type 2 diabetes mellitus , 2014, Diabetic medicine : a journal of the British Diabetic Association.

[12]  T. Meyer,et al.  Uremic solutes and risk of end stage renal disease in type 2 diabetes , 2014, Kidney international.

[13]  E. Boerwinkle,et al.  Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study. , 2013, American journal of epidemiology.

[14]  M. Knip,et al.  Incidence of type 1 diabetes in Finland. , 2013, JAMA.

[15]  Fabian J Theis,et al.  Metabolite profiling reveals new insights into the regulation of serum urate in humans , 2013, Metabolomics.

[16]  G. Schernthaner,et al.  Diabetic nephropathy: new approaches for improving glycemic control and reducing risk. , 2013, Journal of nephrology.

[17]  Yu Cao,et al.  Random Forest in Clinical Metabolomics for Phenotypic Discrimination and Biomarker Selection , 2013, Evidence-based complementary and alternative medicine : eCAM.

[18]  J. Skupień,et al.  The early decline in renal function in patients with type 1 diabetes and proteinuria predicts the risk of end stage renal disease , 2012, Kidney international.

[19]  Kimmo Kaski,et al.  Metabolic diversity of progressive kidney disease in 325 patients with type 1 diabetes (the FinnDiane Study). , 2012, Journal of proteome research.

[20]  Thomas Brendan Murphy,et al.  Applying random forests to identify biomarker panels in serum 2D-DIGE data for the detection and staging of prostate cancer. , 2011, Journal of proteome research.

[21]  T. Hankemeier,et al.  Discovery of early-stage biomarkers for diabetic kidney disease using ms-based metabolomics (FinnDiane study) , 2011, Metabolomics.

[22]  K. Kinzler,et al.  Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome , 2011, Proceedings of the National Academy of Sciences.

[23]  J. Nicholson,et al.  Dietary modulation of gut functional ecology studied by fecal metabonomics. , 2010, Journal of proteome research.

[24]  Andrea Natali,et al.  α-Hydroxybutyrate Is an Early Biomarker of Insulin Resistance and Glucose Intolerance in a Nondiabetic Population , 2010, PloS one.

[25]  Corey D. DeHaven,et al.  Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. , 2009, Analytical chemistry.

[26]  C. Schmid,et al.  A new equation to estimate glomerular filtration rate. , 2009, Annals of internal medicine.

[27]  Merlin C. Thomas,et al.  The Presence and Severity of Chronic Kidney Disease Predicts All-Cause Mortality in Type 1 Diabetes , 2009, Diabetes.

[28]  W. Katon,et al.  Diabetes complications severity index and risk of mortality, hospitalization, and healthcare utilization. , 2008, The American journal of managed care.

[29]  Merlin C. Thomas,et al.  Metabolic syndrome in type 1 diabetes: association with diabetic nephropathy and glycemic control (the FinnDiane study). , 2005, Diabetes care.

[30]  Michael Brownlee,et al.  The pathobiology of diabetic complications: a unifying mechanism. , 2005, Diabetes.

[31]  Monya Baker,et al.  In biomarkers we trust? , 2005, Nature Biotechnology.

[32]  Leo Breiman,et al.  Random Forests , 2001, Machine Learning.

[33]  J. García,et al.  Characterization of the hca Cluster Encoding the Dioxygenolytic Pathway for Initial Catabolism of 3-Phenylpropionic Acid in Escherichia coliK-12 , 1998, Journal of bacteriology.

[34]  S. Kreiner,et al.  Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus. , 1987, British medical journal.

[35]  A. Folsom,et al.  The ARIC Study , 2019 .

[36]  M. Cooper,et al.  Mechanisms of diabetic complications. , 2013, Physiological reviews.

[37]  Andy Liaw,et al.  Classification and Regression by randomForest , 2007 .

[38]  M. Milburn,et al.  Metabolon, Inc. , 2007, Pharmacogenomics.